Executive Officers



President

Qingyi Wei, MD, PhD
Professor of Medicine, Duke University School of Medicine
Associate Director, Duke Cancer Institute, Duke University Medical Center
My research focuses on molecular epidemiology of cancer etiology, including genome-wide association studies and pathway-based analysis of susceptibility loci for cancer risk.


Past President
Shi-Yuan Cheng, PhD
Professor of Neurology (Neuro-oncology)
Northwest University Feiberg School of Medicine
My research focuses on molecular mechanisms and signaling pathways of human cancer initiation, tumorigenesis, invasion, metastases and angiogenesis, and to develop novel approaches for anti-cancer therapies.


Past and Past President
Wei Zhang, PhD
Hanes and Willis Family Professor in Cancer
Director, Cancer Genomics and Precision Medicine
Wake Forest Baptist Comprehensive Cancer Center
My research focuses on cancer genomics by gene and protein expression profiling, identification and functional characterization of cancer genes, and gene regulatory network.


Managing Director
Li Yan, PhD, MD.
Director, Clinical Oncology
Merck & Co. Inc.
My career goal is to develop innovative and personalized medicines for cancer patients. Currently, I manage global clinical trials of novel cancer therapeutics and bridge clinicians and research scientists between US and China.


Chief Newspaper Editor, Director of Public Relations, Director of Multimedia, Director of Membership
Kaylee Yan


Secretarial General
Yunguang Tong, PhD
Assistant Professor
Cedars-Sinai Medical Center, David Geffen School of Medicine, UCLA
My research interests are in developing cancer prevention and treatment agents for colon, breast and pancreatic cancers. My current focus is to investigate PTTG1 (Pituitary Tumor Transforming Gene-1) functions in regulating cancer cell response to HDAC inhibitors, Aurora Kinase inhibitors and ROS-generating drugs. My long term goal is to develop PTTG1 into biomarker for treatment efficacy prediction.


Treasurer
Weimin Qi, MD, PhD
Director of Antibody Development
Biocare Medical, LLC.
My research interests are Antibody-based cancer early detection and cancer immunotherapy, especially breast cancer and prostate cancer.


Source:: 
Internet
Group: